| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Food Hypersensitivity | 75 | 2024 | 737 | 15.190 |
Why?
|
| Peanut Hypersensitivity | 51 | 2023 | 217 | 14.260 |
Why?
|
| Allergens | 101 | 2024 | 1436 | 10.480 |
Why?
|
| Hypersensitivity | 46 | 2025 | 1168 | 9.880 |
Why?
|
| Desensitization, Immunologic | 59 | 2024 | 544 | 9.850 |
Why?
|
| Climate Change | 19 | 2024 | 509 | 6.640 |
Why?
|
| Immunoglobulin E | 62 | 2024 | 1481 | 5.310 |
Why?
|
| Asthma | 65 | 2024 | 6270 | 4.910 |
Why?
|
| Air Pollution | 22 | 2024 | 2380 | 4.470 |
Why?
|
| Dermatitis, Atopic | 18 | 2024 | 729 | 3.420 |
Why?
|
| Air Pollutants | 21 | 2024 | 2923 | 3.390 |
Why?
|
| T-Lymphocytes, Regulatory | 28 | 2022 | 3111 | 2.830 |
Why?
|
| Anti-Allergic Agents | 15 | 2018 | 153 | 2.710 |
Why?
|
| Immune Tolerance | 27 | 2024 | 2324 | 2.550 |
Why?
|
| Basophils | 18 | 2024 | 392 | 2.500 |
Why?
|
| Plant Proteins | 13 | 2022 | 374 | 2.430 |
Why?
|
| Environmental Exposure | 29 | 2024 | 4544 | 2.310 |
Why?
|
| Antigens, Plant | 18 | 2023 | 103 | 2.250 |
Why?
|
| Particulate Matter | 16 | 2024 | 2624 | 2.200 |
Why?
|
| Eosinophilic Esophagitis | 10 | 2023 | 206 | 2.200 |
Why?
|
| Epigenesis, Genetic | 17 | 2024 | 3819 | 2.180 |
Why?
|
| Cytokines | 43 | 2025 | 7421 | 2.090 |
Why?
|
| Antibodies, Anti-Idiotypic | 10 | 2018 | 340 | 2.090 |
Why?
|
| Nut Hypersensitivity | 8 | 2023 | 33 | 2.070 |
Why?
|
| Anaphylaxis | 11 | 2023 | 739 | 2.060 |
Why?
|
| Food | 15 | 2024 | 764 | 1.850 |
Why?
|
| Administration, Oral | 33 | 2024 | 4015 | 1.830 |
Why?
|
| Immunotherapy | 20 | 2023 | 4752 | 1.770 |
Why?
|
| Th2 Cells | 13 | 2025 | 1075 | 1.660 |
Why?
|
| Emollients | 4 | 2023 | 41 | 1.630 |
Why?
|
| Humans | 387 | 2025 | 765968 | 1.450 |
Why?
|
| STAT5 Transcription Factor | 5 | 2022 | 269 | 1.400 |
Why?
|
| Forkhead Transcription Factors | 10 | 2021 | 1624 | 1.390 |
Why?
|
| DNA Methylation | 15 | 2024 | 4424 | 1.250 |
Why?
|
| Interleukin-10 | 9 | 2023 | 1183 | 1.220 |
Why?
|
| Fossil Fuels | 3 | 2024 | 53 | 1.220 |
Why?
|
| Milk Hypersensitivity | 7 | 2024 | 83 | 1.200 |
Why?
|
| CD4-Positive T-Lymphocytes | 11 | 2021 | 4405 | 1.170 |
Why?
|
| Rhinitis, Allergic, Seasonal | 3 | 2020 | 101 | 1.140 |
Why?
|
| Hypersensitivity, Immediate | 4 | 2023 | 346 | 1.140 |
Why?
|
| Environmental Pollution | 3 | 2022 | 125 | 1.110 |
Why?
|
| Eosinophils | 6 | 2022 | 945 | 1.080 |
Why?
|
| T-Lymphocyte Subsets | 9 | 2020 | 1811 | 1.080 |
Why?
|
| Egg Hypersensitivity | 2 | 2019 | 47 | 1.070 |
Why?
|
| Immunity, Innate | 15 | 2025 | 3081 | 1.050 |
Why?
|
| Child | 97 | 2024 | 80564 | 1.040 |
Why?
|
| Ozone | 4 | 2023 | 499 | 1.020 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 3 | 2021 | 975 | 1.010 |
Why?
|
| Global Warming | 5 | 2024 | 79 | 1.010 |
Why?
|
| Biological Products | 5 | 2024 | 942 | 1.010 |
Why?
|
| Environmental Pollutants | 4 | 2024 | 1290 | 1.000 |
Why?
|
| Immune System | 4 | 2023 | 799 | 0.990 |
Why?
|
| Allergy and Immunology | 2 | 2019 | 169 | 0.990 |
Why?
|
| Th1 Cells | 6 | 2021 | 1039 | 0.980 |
Why?
|
| CD8-Positive T-Lymphocytes | 11 | 2024 | 4642 | 0.960 |
Why?
|
| Nitrogen Dioxide | 4 | 2024 | 538 | 0.950 |
Why?
|
| Immunoglobulin G | 19 | 2024 | 4528 | 0.950 |
Why?
|
| Vehicle Emissions | 3 | 2024 | 651 | 0.900 |
Why?
|
| Arsenic | 3 | 2017 | 356 | 0.890 |
Why?
|
| Pollen | 2 | 2021 | 79 | 0.880 |
Why?
|
| CpG Islands | 5 | 2021 | 1207 | 0.840 |
Why?
|
| Epigenomics | 4 | 2024 | 959 | 0.840 |
Why?
|
| Antibodies, Monoclonal | 10 | 2023 | 9249 | 0.820 |
Why?
|
| Photosynthesis | 1 | 2023 | 69 | 0.820 |
Why?
|
| Motor Vehicles | 2 | 2024 | 280 | 0.820 |
Why?
|
| Respiratory Mucosa | 2 | 2020 | 438 | 0.820 |
Why?
|
| Greenhouse Effect | 1 | 2022 | 31 | 0.820 |
Why?
|
| Climate | 2 | 2023 | 147 | 0.810 |
Why?
|
| Antibodies, Viral | 14 | 2023 | 3211 | 0.800 |
Why?
|
| Complement Activation | 1 | 2024 | 431 | 0.800 |
Why?
|
| B-Lymphocytes | 14 | 2024 | 4778 | 0.790 |
Why?
|
| Adolescent | 79 | 2024 | 88835 | 0.780 |
Why?
|
| Heat-Shock Response | 1 | 2023 | 179 | 0.770 |
Why?
|
| Dendritic Cells | 9 | 2021 | 2747 | 0.760 |
Why?
|
| Autoimmune Diseases | 6 | 2023 | 2226 | 0.760 |
Why?
|
| Child, Preschool | 52 | 2024 | 42500 | 0.760 |
Why?
|
| Premature Birth | 2 | 2024 | 1829 | 0.750 |
Why?
|
| Excipients | 1 | 2021 | 95 | 0.740 |
Why?
|
| Schools, Medical | 2 | 2021 | 876 | 0.740 |
Why?
|
| Carbon Monoxide | 3 | 2021 | 560 | 0.730 |
Why?
|
| 2S Albumins, Plant | 7 | 2023 | 37 | 0.730 |
Why?
|
| Esophagus | 3 | 2013 | 1037 | 0.730 |
Why?
|
| Supreme Court Decisions | 1 | 2022 | 135 | 0.720 |
Why?
|
| Public Health | 4 | 2023 | 2680 | 0.720 |
Why?
|
| United Nations | 1 | 2021 | 151 | 0.710 |
Why?
|
| Water Pollutants, Chemical | 2 | 2022 | 358 | 0.700 |
Why?
|
| Eczema | 2 | 2020 | 246 | 0.700 |
Why?
|
| Animals | 102 | 2025 | 168764 | 0.690 |
Why?
|
| Female | 144 | 2024 | 396112 | 0.690 |
Why?
|
| T-Lymphocytes | 17 | 2024 | 10261 | 0.680 |
Why?
|
| Inhalation Exposure | 2 | 2021 | 432 | 0.680 |
Why?
|
| Infant | 42 | 2024 | 36386 | 0.680 |
Why?
|
| Lymphocytes | 6 | 2024 | 2599 | 0.680 |
Why?
|
| Skin | 9 | 2024 | 4489 | 0.680 |
Why?
|
| Federal Government | 1 | 2022 | 265 | 0.680 |
Why?
|
| HLA-A2 Antigen | 1 | 2020 | 207 | 0.670 |
Why?
|
| Immunologic Tests | 3 | 2020 | 101 | 0.670 |
Why?
|
| Immunologic Factors | 8 | 2023 | 1587 | 0.660 |
Why?
|
| Laboratories | 1 | 2023 | 462 | 0.660 |
Why?
|
| Maternal Exposure | 5 | 2024 | 1095 | 0.650 |
Why?
|
| Milk | 3 | 2019 | 436 | 0.640 |
Why?
|
| California | 8 | 2021 | 1436 | 0.630 |
Why?
|
| Enterocolitis | 1 | 2020 | 107 | 0.630 |
Why?
|
| Vaccines | 3 | 2023 | 841 | 0.620 |
Why?
|
| Male | 143 | 2024 | 363698 | 0.620 |
Why?
|
| Cross Reactions | 5 | 2021 | 824 | 0.620 |
Why?
|
| Fetal Blood | 5 | 2024 | 1369 | 0.620 |
Why?
|
| Environment | 3 | 2023 | 1114 | 0.610 |
Why?
|
| Double-Blind Method | 23 | 2022 | 12437 | 0.600 |
Why?
|
| Fungi | 1 | 2021 | 348 | 0.600 |
Why?
|
| Asthma, Exercise-Induced | 1 | 2018 | 23 | 0.600 |
Why?
|
| Adult | 92 | 2024 | 223044 | 0.590 |
Why?
|
| Egg Proteins, Dietary | 1 | 2017 | 6 | 0.580 |
Why?
|
| Fires | 1 | 2019 | 170 | 0.580 |
Why?
|
| Skin Tests | 8 | 2020 | 630 | 0.570 |
Why?
|
| Air Pollution, Indoor | 3 | 2024 | 931 | 0.570 |
Why?
|
| Detergents | 3 | 2023 | 235 | 0.550 |
Why?
|
| Lymphocyte Activation | 11 | 2017 | 5501 | 0.520 |
Why?
|
| Young Adult | 51 | 2022 | 59889 | 0.520 |
Why?
|
| Twins, Monozygotic | 4 | 2019 | 469 | 0.520 |
Why?
|
| Cadmium | 1 | 2017 | 218 | 0.510 |
Why?
|
| Immunity | 2 | 2021 | 1002 | 0.510 |
Why?
|
| Biological Therapy | 1 | 2017 | 140 | 0.500 |
Why?
|
| Polyethylene Glycols | 1 | 2021 | 1188 | 0.500 |
Why?
|
| Rhinitis | 4 | 2023 | 752 | 0.500 |
Why?
|
| Anacardium | 3 | 2023 | 6 | 0.500 |
Why?
|
| Blood Pressure | 3 | 2021 | 8532 | 0.490 |
Why?
|
| Medical Informatics | 1 | 2022 | 745 | 0.490 |
Why?
|
| Monocytes | 7 | 2023 | 2595 | 0.490 |
Why?
|
| Lectins, C-Type | 4 | 2023 | 592 | 0.490 |
Why?
|
| Schools | 1 | 2024 | 1492 | 0.480 |
Why?
|
| Severe Combined Immunodeficiency | 3 | 2015 | 235 | 0.480 |
Why?
|
| Epinephrine | 3 | 2023 | 783 | 0.480 |
Why?
|
| Gastroesophageal Reflux | 3 | 2013 | 833 | 0.470 |
Why?
|
| Antigen-Presenting Cells | 2 | 2021 | 962 | 0.470 |
Why?
|
| Epithelial Cells | 9 | 2024 | 3681 | 0.460 |
Why?
|
| Phleum | 2 | 2020 | 5 | 0.450 |
Why?
|
| Histones | 1 | 2024 | 2584 | 0.450 |
Why?
|
| Epitope Mapping | 4 | 2022 | 300 | 0.430 |
Why?
|
| Sympathomimetics | 1 | 2013 | 56 | 0.430 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2014 | 2796 | 0.420 |
Why?
|
| Research | 4 | 2019 | 1975 | 0.420 |
Why?
|
| Mast Cells | 5 | 2022 | 1412 | 0.420 |
Why?
|
| Infant, Newborn | 15 | 2024 | 26346 | 0.420 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 4 | 2024 | 3247 | 0.420 |
Why?
|
| Tobacco Smoke Pollution | 2 | 2024 | 827 | 0.410 |
Why?
|
| HLA-DR Antigens | 2 | 2015 | 608 | 0.410 |
Why?
|
| Peptides | 5 | 2023 | 4331 | 0.410 |
Why?
|
| Epithelium | 6 | 2024 | 1599 | 0.410 |
Why?
|
| Immunophenotyping | 6 | 2024 | 1866 | 0.410 |
Why?
|
| Common Variable Immunodeficiency | 2 | 2015 | 99 | 0.410 |
Why?
|
| Pregnancy | 21 | 2024 | 30260 | 0.400 |
Why?
|
| Interferon-gamma | 10 | 2022 | 3160 | 0.400 |
Why?
|
| Mites | 1 | 2012 | 46 | 0.400 |
Why?
|
| Severity of Illness Index | 14 | 2022 | 15880 | 0.400 |
Why?
|
| Immunologic Memory | 6 | 2021 | 1375 | 0.400 |
Why?
|
| Basophil Degranulation Test | 3 | 2023 | 20 | 0.400 |
Why?
|
| Interleukin-7 Receptor alpha Subunit | 2 | 2009 | 50 | 0.390 |
Why?
|
| Intestinal Mucosa | 4 | 2023 | 3046 | 0.390 |
Why?
|
| Immunity, Cellular | 3 | 2021 | 1555 | 0.390 |
Why?
|
| Ribosomal Protein S6 | 1 | 2012 | 70 | 0.390 |
Why?
|
| Seed Storage Proteins | 4 | 2021 | 15 | 0.380 |
Why?
|
| Cardiovascular System | 1 | 2019 | 841 | 0.380 |
Why?
|
| Polyendocrinopathies, Autoimmune | 2 | 2011 | 56 | 0.380 |
Why?
|
| Pyrophosphatases | 2 | 2016 | 141 | 0.370 |
Why?
|
| Milk Proteins | 3 | 2018 | 161 | 0.370 |
Why?
|
| Eukaryotic Initiation Factor-4E | 1 | 2012 | 111 | 0.370 |
Why?
|
| Metabolomics | 4 | 2024 | 1668 | 0.360 |
Why?
|
| Phosphoric Diester Hydrolases | 2 | 2016 | 204 | 0.360 |
Why?
|
| Middle Aged | 55 | 2024 | 223009 | 0.360 |
Why?
|
| Delivery of Health Care | 4 | 2023 | 5370 | 0.350 |
Why?
|
| Paraffin | 2 | 2020 | 36 | 0.350 |
Why?
|
| Autoantibodies | 7 | 2023 | 2113 | 0.350 |
Why?
|
| Heat-Shock Proteins | 5 | 1994 | 791 | 0.340 |
Why?
|
| Interleukin-4 | 5 | 2022 | 1162 | 0.340 |
Why?
|
| Picornaviridae Infections | 2 | 2021 | 97 | 0.340 |
Why?
|
| Prenatal Exposure Delayed Effects | 4 | 2024 | 2531 | 0.330 |
Why?
|
| Proteomics | 8 | 2023 | 3910 | 0.330 |
Why?
|
| Computational Biology | 4 | 2021 | 3559 | 0.330 |
Why?
|
| Gastrointestinal Tract | 4 | 2022 | 834 | 0.330 |
Why?
|
| Dust | 1 | 2012 | 489 | 0.320 |
Why?
|
| Receptors, IgE | 3 | 2021 | 374 | 0.320 |
Why?
|
| Flow Cytometry | 12 | 2024 | 5881 | 0.320 |
Why?
|
| Epitopes | 5 | 2023 | 2523 | 0.320 |
Why?
|
| Nasal Polyps | 2 | 2014 | 412 | 0.310 |
Why?
|
| Chemokines, C | 1 | 2008 | 10 | 0.310 |
Why?
|
| Inflammation | 14 | 2024 | 10850 | 0.310 |
Why?
|
| Cells, Cultured | 13 | 2020 | 18973 | 0.310 |
Why?
|
| Universities | 1 | 2014 | 998 | 0.310 |
Why?
|
| United States | 22 | 2024 | 72903 | 0.310 |
Why?
|
| Receptors, Immunologic | 4 | 2023 | 1415 | 0.310 |
Why?
|
| Vaccination | 8 | 2024 | 3426 | 0.300 |
Why?
|
| Metabolome | 4 | 2024 | 1005 | 0.300 |
Why?
|
| Fas Ligand Protein | 1 | 2008 | 214 | 0.290 |
Why?
|
| Lung Diseases | 3 | 2018 | 1940 | 0.290 |
Why?
|
| Treatment Outcome | 25 | 2023 | 65188 | 0.290 |
Why?
|
| Probiotics | 3 | 2024 | 387 | 0.290 |
Why?
|
| Hot Temperature | 4 | 2024 | 1433 | 0.290 |
Why?
|
| Single-Cell Analysis | 6 | 2024 | 2535 | 0.290 |
Why?
|
| Graft Rejection | 11 | 2000 | 4499 | 0.280 |
Why?
|
| Quality of Life | 9 | 2023 | 13462 | 0.280 |
Why?
|
| Mercury | 2 | 2021 | 291 | 0.280 |
Why?
|
| Disease Susceptibility | 3 | 2024 | 1789 | 0.280 |
Why?
|
| Gene Expression | 8 | 2021 | 7584 | 0.270 |
Why?
|
| Receptors, IgG | 2 | 2020 | 559 | 0.270 |
Why?
|
| Genetic Predisposition to Disease | 10 | 2024 | 18071 | 0.270 |
Why?
|
| STAT Transcription Factors | 1 | 2007 | 189 | 0.270 |
Why?
|
| Cell Adhesion Molecules | 5 | 2021 | 1612 | 0.270 |
Why?
|
| Gene Expression Profiling | 8 | 2024 | 9525 | 0.270 |
Why?
|
| Rhinovirus | 4 | 2021 | 210 | 0.270 |
Why?
|
| Neutropenia | 2 | 2009 | 893 | 0.270 |
Why?
|
| Leukocyte Count | 5 | 2022 | 1602 | 0.260 |
Why?
|
| Forced Expiratory Volume | 5 | 2018 | 1828 | 0.260 |
Why?
|
| Administration, Sublingual | 3 | 2019 | 60 | 0.260 |
Why?
|
| Seasons | 2 | 2023 | 1524 | 0.260 |
Why?
|
| Adrenal Cortex Hormones | 4 | 2021 | 1880 | 0.260 |
Why?
|
| Growth Disorders | 1 | 2011 | 633 | 0.260 |
Why?
|
| Pilot Projects | 9 | 2022 | 8733 | 0.260 |
Why?
|
| Gene Rearrangement, B-Lymphocyte | 3 | 2018 | 111 | 0.260 |
Why?
|
| Bronchi | 3 | 2018 | 843 | 0.260 |
Why?
|
| Phenotype | 13 | 2024 | 16721 | 0.250 |
Why?
|
| Epitopes, T-Lymphocyte | 4 | 2023 | 825 | 0.250 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2012 | 1801 | 0.250 |
Why?
|
| Immunologic Deficiency Syndromes | 3 | 2015 | 548 | 0.250 |
Why?
|
| Sinusitis | 2 | 2014 | 995 | 0.240 |
Why?
|
| Plastics | 2 | 2022 | 117 | 0.240 |
Why?
|
| Seeds | 3 | 2020 | 124 | 0.240 |
Why?
|
| Mucous Membrane | 3 | 2023 | 657 | 0.240 |
Why?
|
| Cattle | 5 | 2021 | 3801 | 0.240 |
Why?
|
| Anti-Asthmatic Agents | 5 | 2021 | 572 | 0.240 |
Why?
|
| Environmental Health | 2 | 2018 | 297 | 0.240 |
Why?
|
| Prevalence | 8 | 2021 | 15842 | 0.240 |
Why?
|
| Adaptive Immunity | 4 | 2024 | 734 | 0.230 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2019 | 3230 | 0.230 |
Why?
|
| Parents | 1 | 2018 | 3592 | 0.230 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2022 | 2056 | 0.230 |
Why?
|
| Propane | 1 | 2024 | 12 | 0.230 |
Why?
|
| Permeability | 3 | 2023 | 726 | 0.230 |
Why?
|
| Benzo(a)pyrene | 1 | 2024 | 26 | 0.230 |
Why?
|
| Chemokines | 1 | 2009 | 956 | 0.230 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2008 | 1347 | 0.230 |
Why?
|
| Glycoproteins | 5 | 2023 | 2195 | 0.230 |
Why?
|
| Pets | 1 | 2024 | 45 | 0.230 |
Why?
|
| Juglans | 2 | 2017 | 45 | 0.230 |
Why?
|
| Kidney Transplantation | 11 | 2000 | 4270 | 0.230 |
Why?
|
| Nuts | 3 | 2020 | 265 | 0.230 |
Why?
|
| Antigens | 2 | 2024 | 1438 | 0.220 |
Why?
|
| Emigration and Immigration | 2 | 1997 | 405 | 0.220 |
Why?
|
| Cats | 2 | 2024 | 972 | 0.220 |
Why?
|
| Interleukin-13 | 4 | 2023 | 388 | 0.220 |
Why?
|
| Histone Code | 1 | 2024 | 159 | 0.220 |
Why?
|
| Tight Junctions | 3 | 2024 | 330 | 0.220 |
Why?
|
| Aged | 29 | 2024 | 171117 | 0.220 |
Why?
|
| Polysorbates | 1 | 2023 | 46 | 0.220 |
Why?
|
| Electricity | 1 | 2024 | 174 | 0.210 |
Why?
|
| Pregnancy Outcome | 3 | 2023 | 2966 | 0.210 |
Why?
|
| Amino Acid Substitution | 1 | 2008 | 1740 | 0.210 |
Why?
|
| Adenosine Triphosphatases | 5 | 1994 | 837 | 0.210 |
Why?
|
| NADH, NADPH Oxidoreductases | 3 | 1992 | 96 | 0.210 |
Why?
|
| Antigens, Surface | 1 | 2007 | 1617 | 0.210 |
Why?
|
| Guanidines | 2 | 1994 | 194 | 0.210 |
Why?
|
| Reference Standards | 3 | 2018 | 1013 | 0.210 |
Why?
|
| West Virginia | 1 | 2022 | 32 | 0.210 |
Why?
|
| Recycling | 1 | 2022 | 16 | 0.210 |
Why?
|
| Receptors, Interleukin-2 | 4 | 2022 | 561 | 0.210 |
Why?
|
| Leukotriene B4 | 1 | 2024 | 281 | 0.210 |
Why?
|
| Advisory Committees | 2 | 2019 | 796 | 0.210 |
Why?
|
| Volatile Organic Compounds | 1 | 2024 | 86 | 0.210 |
Why?
|
| Monkeypox virus | 1 | 2023 | 43 | 0.200 |
Why?
|
| STAT6 Transcription Factor | 2 | 2014 | 197 | 0.200 |
Why?
|
| Antibodies, Neutralizing | 6 | 2022 | 2010 | 0.200 |
Why?
|
| Rats, Inbred Lew | 18 | 2024 | 1167 | 0.200 |
Why?
|
| Coronavirus Infections | 4 | 2020 | 3100 | 0.200 |
Why?
|
| Mass Spectrometry | 2 | 2020 | 2194 | 0.200 |
Why?
|
| Mice | 23 | 2024 | 81819 | 0.200 |
Why?
|
| Pneumonia, Viral | 4 | 2020 | 3223 | 0.200 |
Why?
|
| Antigens, CD | 9 | 2018 | 4025 | 0.200 |
Why?
|
| Tetanus | 1 | 2022 | 52 | 0.200 |
Why?
|
| Inheritance Patterns | 1 | 2024 | 345 | 0.200 |
Why?
|
| Placenta | 3 | 2023 | 1728 | 0.200 |
Why?
|
| Twins | 2 | 2021 | 341 | 0.200 |
Why?
|
| Avidin | 2 | 2023 | 44 | 0.200 |
Why?
|
| Hypertension, Pulmonary | 3 | 2024 | 1604 | 0.200 |
Why?
|
| United States Environmental Protection Agency | 1 | 2022 | 139 | 0.200 |
Why?
|
| Crithidia fasciculata | 4 | 1998 | 4 | 0.190 |
Why?
|
| United States Food and Drug Administration | 2 | 2021 | 1672 | 0.190 |
Why?
|
| Body Fluids | 1 | 2024 | 321 | 0.190 |
Why?
|
| Th17 Cells | 3 | 2021 | 786 | 0.190 |
Why?
|
| Mutation | 15 | 2020 | 30198 | 0.190 |
Why?
|
| Comorbidity | 7 | 2022 | 10563 | 0.190 |
Why?
|
| Immunoglobulin A | 3 | 2022 | 995 | 0.190 |
Why?
|
| Power Plants | 1 | 2022 | 125 | 0.190 |
Why?
|
| Soil | 1 | 2022 | 123 | 0.190 |
Why?
|
| United States Dept. of Health and Human Services | 1 | 2022 | 88 | 0.190 |
Why?
|
| Immunosuppressive Agents | 8 | 2014 | 4209 | 0.190 |
Why?
|
| Enteritis | 1 | 2023 | 163 | 0.190 |
Why?
|
| Respiratory Tract Diseases | 2 | 2019 | 744 | 0.190 |
Why?
|
| Smoke | 1 | 2023 | 243 | 0.190 |
Why?
|
| Expert Testimony | 2 | 2020 | 266 | 0.190 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2024 | 1957 | 0.190 |
Why?
|
| Convalescence | 1 | 2021 | 107 | 0.180 |
Why?
|
| Clinical Trials as Topic | 7 | 2022 | 8041 | 0.180 |
Why?
|
| Nasal Obstruction | 1 | 2023 | 162 | 0.180 |
Why?
|
| Autoantigens | 4 | 2023 | 883 | 0.180 |
Why?
|
| Placebos | 3 | 2021 | 1659 | 0.180 |
Why?
|
| Spores, Fungal | 1 | 2021 | 90 | 0.180 |
Why?
|
| Disease Models, Animal | 8 | 2024 | 18293 | 0.180 |
Why?
|
| Artificial Intelligence | 3 | 2024 | 2659 | 0.180 |
Why?
|
| Wiskott-Aldrich Syndrome Protein | 2 | 2012 | 163 | 0.180 |
Why?
|
| Pistacia | 1 | 2020 | 7 | 0.180 |
Why?
|
| Petrolatum | 1 | 2020 | 7 | 0.180 |
Why?
|
| Academies and Institutes | 2 | 2020 | 326 | 0.180 |
Why?
|
| Medical History Taking | 2 | 2015 | 777 | 0.170 |
Why?
|
| Nitrogen Oxides | 1 | 2020 | 128 | 0.170 |
Why?
|
| Education, Medical | 2 | 2023 | 1746 | 0.170 |
Why?
|
| Cells | 1 | 2021 | 162 | 0.170 |
Why?
|
| Genome-Wide Association Study | 7 | 2024 | 12807 | 0.170 |
Why?
|
| Pandemics | 9 | 2022 | 8703 | 0.170 |
Why?
|
| Dipeptidyl Peptidase 4 | 1 | 2020 | 92 | 0.170 |
Why?
|
| Phosphorylation | 6 | 2012 | 8278 | 0.170 |
Why?
|
| Mass Vaccination | 1 | 2021 | 111 | 0.170 |
Why?
|
| Trees | 1 | 2020 | 58 | 0.170 |
Why?
|
| Curriculum | 3 | 2023 | 3782 | 0.170 |
Why?
|
| Genes, Immunoglobulin Heavy Chain | 2 | 2010 | 58 | 0.170 |
Why?
|
| Vital Capacity | 3 | 2018 | 995 | 0.170 |
Why?
|
| Chemokine CCL1 | 2 | 2010 | 22 | 0.170 |
Why?
|
| Pyroglyphidae | 2 | 2019 | 94 | 0.170 |
Why?
|
| Cell Degranulation | 1 | 2020 | 280 | 0.170 |
Why?
|
| Diet | 4 | 2023 | 8086 | 0.160 |
Why?
|
| Triticum | 2 | 2018 | 92 | 0.160 |
Why?
|
| Cardiovascular Diseases | 3 | 2020 | 15652 | 0.160 |
Why?
|
| Vaccines, Synthetic | 4 | 2023 | 621 | 0.160 |
Why?
|
| Cell Movement | 2 | 2010 | 5194 | 0.160 |
Why?
|
| Knowledge | 1 | 2021 | 178 | 0.160 |
Why?
|
| Cyclosporine | 5 | 1998 | 778 | 0.160 |
Why?
|
| Immunoconjugates | 5 | 1998 | 981 | 0.160 |
Why?
|
| Intercellular Adhesion Molecule-1 | 5 | 2020 | 1132 | 0.160 |
Why?
|
| Azetidines | 1 | 2020 | 150 | 0.160 |
Why?
|
| Health Policy | 2 | 2024 | 2698 | 0.160 |
Why?
|
| Alanine | 2 | 2020 | 612 | 0.160 |
Why?
|
| Fluorocarbons | 1 | 2024 | 497 | 0.160 |
Why?
|
| Adenosine Monophosphate | 1 | 2020 | 231 | 0.160 |
Why?
|
| Spermidine | 3 | 1998 | 63 | 0.160 |
Why?
|
| Germinal Center | 1 | 2022 | 379 | 0.160 |
Why?
|
| World Health Organization | 2 | 2023 | 1328 | 0.160 |
Why?
|
| Wheat Hypersensitivity | 1 | 2018 | 11 | 0.160 |
Why?
|
| Tumor Necrosis Factor-alpha | 7 | 2020 | 4348 | 0.160 |
Why?
|
| New Hampshire | 2 | 2019 | 174 | 0.150 |
Why?
|
| Coronavirus | 1 | 2021 | 155 | 0.150 |
Why?
|
| CD40 Ligand | 1 | 2000 | 528 | 0.150 |
Why?
|
| Vulnerable Populations | 1 | 2024 | 718 | 0.150 |
Why?
|
| DNA | 2 | 2015 | 7202 | 0.150 |
Why?
|
| Factor VIII | 1 | 2000 | 347 | 0.150 |
Why?
|
| Environmental Policy | 1 | 2018 | 36 | 0.150 |
Why?
|
| Cross-Sectional Studies | 8 | 2022 | 26318 | 0.150 |
Why?
|
| Twins, Dizygotic | 2 | 2019 | 236 | 0.150 |
Why?
|
| Agglutination | 1 | 2017 | 42 | 0.150 |
Why?
|
| Diet, Reducing | 1 | 2021 | 487 | 0.150 |
Why?
|
| Oxidative Stress | 4 | 2024 | 3141 | 0.150 |
Why?
|
| Antibody Affinity | 1 | 2018 | 251 | 0.150 |
Why?
|
| Environmental Monitoring | 2 | 2022 | 1470 | 0.150 |
Why?
|
| Perforin | 2 | 2008 | 166 | 0.140 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2021 | 497 | 0.140 |
Why?
|
| Eosinophilia | 2 | 2021 | 556 | 0.140 |
Why?
|
| Receptors, Interleukin-13 | 1 | 2017 | 13 | 0.140 |
Why?
|
| Receptors, Interleukin-5 | 1 | 2017 | 20 | 0.140 |
Why?
|
| Chemokine CCL5 | 4 | 1997 | 213 | 0.140 |
Why?
|
| Research Support as Topic | 1 | 2022 | 696 | 0.140 |
Why?
|
| Case-Control Studies | 9 | 2021 | 22223 | 0.140 |
Why?
|
| Feces | 2 | 2022 | 1504 | 0.140 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2018 | 241 | 0.140 |
Why?
|
| Gene Expression Regulation | 9 | 2021 | 11888 | 0.140 |
Why?
|
| Gene Regulatory Networks | 2 | 2024 | 1748 | 0.140 |
Why?
|
| Egg Proteins | 1 | 2017 | 58 | 0.140 |
Why?
|
| Monitoring, Immunologic | 1 | 2017 | 99 | 0.140 |
Why?
|
| Feedback | 1 | 2021 | 796 | 0.140 |
Why?
|
| Purines | 1 | 2020 | 615 | 0.140 |
Why?
|
| Immunoglobulin Heavy Chains | 2 | 2021 | 648 | 0.140 |
Why?
|
| Risk Factors | 9 | 2021 | 74840 | 0.140 |
Why?
|
| Interleukin-4 Receptor alpha Subunit | 1 | 2017 | 57 | 0.140 |
Why?
|
| Cannabis | 1 | 2023 | 446 | 0.140 |
Why?
|
| Glutathione | 4 | 1998 | 588 | 0.140 |
Why?
|
| Endothelial Cells | 2 | 2020 | 3584 | 0.140 |
Why?
|
| Disasters | 1 | 2023 | 520 | 0.140 |
Why?
|
| Reperfusion Injury | 7 | 1997 | 1042 | 0.140 |
Why?
|
| Up-Regulation | 6 | 2022 | 4137 | 0.140 |
Why?
|
| Metabolic Diseases | 1 | 2023 | 687 | 0.140 |
Why?
|
| Health Facilities | 1 | 2022 | 577 | 0.140 |
Why?
|
| Viral Vaccines | 1 | 2022 | 597 | 0.140 |
Why?
|
| Drug Eruptions | 1 | 2020 | 335 | 0.140 |
Why?
|
| Trypanosoma cruzi | 3 | 1994 | 200 | 0.130 |
Why?
|
| Carya | 1 | 2016 | 2 | 0.130 |
Why?
|
| Adolescent Development | 1 | 2020 | 275 | 0.130 |
Why?
|
| Interleukin-7 | 2 | 2021 | 147 | 0.130 |
Why?
|
| Athletes | 1 | 2024 | 1162 | 0.130 |
Why?
|
| Awareness | 1 | 2021 | 653 | 0.130 |
Why?
|
| Chemotaxis | 2 | 2010 | 596 | 0.130 |
Why?
|
| Immunoglobulins | 1 | 2019 | 852 | 0.130 |
Why?
|
| Antigens, Dermatophagoides | 1 | 2016 | 101 | 0.130 |
Why?
|
| Neutrophils | 3 | 2022 | 3776 | 0.130 |
Why?
|
| Nuclear Proteins | 3 | 2015 | 5783 | 0.130 |
Why?
|
| Killer Cells, Natural | 2 | 2022 | 2210 | 0.130 |
Why?
|
| Molecular Mimicry | 1 | 2017 | 210 | 0.130 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2020 | 702 | 0.130 |
Why?
|
| Child Welfare | 2 | 2017 | 521 | 0.130 |
Why?
|
| Antibody Formation | 4 | 2022 | 1391 | 0.130 |
Why?
|
| Signal Transduction | 6 | 2022 | 23601 | 0.130 |
Why?
|
| Methylation | 2 | 2020 | 1073 | 0.130 |
Why?
|
| Gliadin | 1 | 2016 | 80 | 0.130 |
Why?
|
| Policy Making | 1 | 2019 | 546 | 0.130 |
Why?
|
| Molecular Targeted Therapy | 2 | 2017 | 2822 | 0.130 |
Why?
|
| RNA | 4 | 2023 | 2717 | 0.120 |
Why?
|
| Thinking | 1 | 2019 | 322 | 0.120 |
Why?
|
| Stress, Physiological | 1 | 2023 | 1402 | 0.120 |
Why?
|
| Confidence Intervals | 1 | 2021 | 2910 | 0.120 |
Why?
|
| Pulmonary Artery | 1 | 2024 | 1935 | 0.120 |
Why?
|
| Growth Substances | 2 | 1997 | 758 | 0.120 |
Why?
|
| Conjunctivitis, Allergic | 1 | 2016 | 124 | 0.120 |
Why?
|
| RNA, Messenger | 9 | 2022 | 12768 | 0.120 |
Why?
|
| Pathology, Molecular | 1 | 2018 | 330 | 0.120 |
Why?
|
| Trypanosoma | 2 | 1992 | 14 | 0.120 |
Why?
|
| Nails | 1 | 2017 | 298 | 0.120 |
Why?
|
| Government Regulation | 1 | 2019 | 525 | 0.120 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 747 | 0.120 |
Why?
|
| Introns | 1 | 2018 | 966 | 0.120 |
Why?
|
| Chronic Disease | 5 | 2023 | 9347 | 0.120 |
Why?
|
| Antioxidants | 1 | 2023 | 1670 | 0.120 |
Why?
|
| Educational Status | 1 | 2022 | 2513 | 0.120 |
Why?
|
| Chemokine CCL2 | 3 | 1997 | 602 | 0.120 |
Why?
|
| Feasibility Studies | 3 | 2022 | 5302 | 0.120 |
Why?
|
| Life Style | 2 | 2024 | 3926 | 0.120 |
Why?
|
| Kidney | 12 | 2000 | 7066 | 0.120 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2015 | 111 | 0.120 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 2015 | 176 | 0.120 |
Why?
|
| HLA-DQ Antigens | 1 | 2015 | 190 | 0.120 |
Why?
|
| Immunomodulation | 2 | 2019 | 547 | 0.120 |
Why?
|
| Mycophenolic Acid | 1 | 1996 | 346 | 0.110 |
Why?
|
| Immunoglobulin Variable Region | 2 | 2018 | 419 | 0.110 |
Why?
|
| Bacterial Infections | 1 | 2022 | 1387 | 0.110 |
Why?
|
| Antiprotozoal Agents | 2 | 1992 | 93 | 0.110 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2024 | 2247 | 0.110 |
Why?
|
| Respiratory Tract Infections | 1 | 2022 | 1008 | 0.110 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2015 | 326 | 0.110 |
Why?
|
| Polymerase Chain Reaction | 5 | 2017 | 6069 | 0.110 |
Why?
|
| Physician's Role | 1 | 2021 | 927 | 0.110 |
Why?
|
| Calpain | 1 | 2014 | 145 | 0.110 |
Why?
|
| Systems Biology | 1 | 2018 | 481 | 0.110 |
Why?
|
| Amino Acid Sequence | 9 | 2022 | 13400 | 0.110 |
Why?
|
| Patient-Centered Care | 1 | 2024 | 1458 | 0.110 |
Why?
|
| Eye Proteins | 1 | 2017 | 628 | 0.110 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2023 | 2878 | 0.110 |
Why?
|
| Clone Cells | 2 | 2015 | 1672 | 0.110 |
Why?
|
| Macrophages | 7 | 2021 | 5772 | 0.110 |
Why?
|
| Diet, Sodium-Restricted | 1 | 2015 | 291 | 0.110 |
Why?
|
| Water | 1 | 2020 | 1417 | 0.110 |
Why?
|
| Patient Care | 1 | 2019 | 629 | 0.110 |
Why?
|
| Consensus Sequence | 1 | 2014 | 362 | 0.110 |
Why?
|
| Bacteria | 2 | 2022 | 2209 | 0.110 |
Why?
|
| Medicine | 1 | 2021 | 942 | 0.110 |
Why?
|
| History, 21st Century | 1 | 2019 | 1574 | 0.110 |
Why?
|
| Amino Acid Isomerases | 1 | 1993 | 31 | 0.110 |
Why?
|
| Hyaluronic Acid | 1 | 2017 | 484 | 0.110 |
Why?
|
| Retinal Degeneration | 1 | 2017 | 413 | 0.110 |
Why?
|
| Intestinal Atresia | 1 | 2013 | 69 | 0.100 |
Why?
|
| Rats | 21 | 2024 | 23707 | 0.100 |
Why?
|
| Diet, Fat-Restricted | 1 | 2015 | 328 | 0.100 |
Why?
|
| Granuloma | 1 | 2015 | 327 | 0.100 |
Why?
|
| Urban Population | 1 | 2021 | 2040 | 0.100 |
Why?
|
| Hospitalization | 5 | 2023 | 10808 | 0.100 |
Why?
|
| HLA Antigens | 3 | 2021 | 1339 | 0.100 |
Why?
|
| Diphtheria Toxin | 1 | 2013 | 253 | 0.100 |
Why?
|
| Liver Failure, Acute | 1 | 2014 | 183 | 0.100 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2014 | 431 | 0.100 |
Why?
|
| Transcription Factors | 4 | 2015 | 12131 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 4562 | 0.100 |
Why?
|
| Hepatitis | 1 | 2014 | 227 | 0.100 |
Why?
|
| Promoter Regions, Genetic | 4 | 2018 | 5786 | 0.100 |
Why?
|
| Primary Prevention | 1 | 2019 | 1187 | 0.100 |
Why?
|
| Body Composition | 1 | 2021 | 2439 | 0.100 |
Why?
|
| Disease Progression | 5 | 2024 | 13632 | 0.100 |
Why?
|
| P-Selectin | 4 | 1998 | 597 | 0.100 |
Why?
|
| Injections, Intramuscular | 1 | 2013 | 552 | 0.100 |
Why?
|
| Transplantation, Homologous | 9 | 2000 | 4860 | 0.100 |
Why?
|
| Receptors, Cell Surface | 1 | 2021 | 2817 | 0.100 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 1994 | 393 | 0.090 |
Why?
|
| Nasal Mucosa | 2 | 2016 | 416 | 0.090 |
Why?
|
| Predictive Value of Tests | 3 | 2020 | 15398 | 0.090 |
Why?
|
| Isoantibodies | 2 | 2009 | 681 | 0.090 |
Why?
|
| Echocardiography | 1 | 2024 | 5045 | 0.090 |
Why?
|
| Specimen Handling | 1 | 2016 | 704 | 0.090 |
Why?
|
| Antiviral Agents | 2 | 2021 | 3050 | 0.090 |
Why?
|
| Dietary Fiber | 1 | 2015 | 767 | 0.090 |
Why?
|
| X-Linked Combined Immunodeficiency Diseases | 1 | 2011 | 24 | 0.090 |
Why?
|
| History, 20th Century | 1 | 2019 | 2761 | 0.090 |
Why?
|
| Proteome | 1 | 2021 | 1899 | 0.090 |
Why?
|
| bcl-X Protein | 1 | 2013 | 414 | 0.090 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2024 | 2159 | 0.090 |
Why?
|
| Vitamin D Deficiency | 1 | 2021 | 1348 | 0.090 |
Why?
|
| Obesity, Abdominal | 1 | 2014 | 369 | 0.090 |
Why?
|
| Drug Therapy, Combination | 2 | 2020 | 6309 | 0.090 |
Why?
|
| Membrane Glycoproteins | 5 | 2023 | 3690 | 0.090 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2015 | 813 | 0.090 |
Why?
|
| Cell Differentiation | 4 | 2022 | 11641 | 0.090 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2020 | 1892 | 0.090 |
Why?
|
| Cell Communication | 3 | 2013 | 1660 | 0.090 |
Why?
|
| Base Sequence | 5 | 2014 | 12403 | 0.090 |
Why?
|
| Gastrointestinal Diseases | 1 | 2019 | 1203 | 0.090 |
Why?
|
| Sulfonamides | 1 | 2020 | 1984 | 0.090 |
Why?
|
| Molecular Sequence Data | 10 | 2018 | 17594 | 0.090 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2014 | 569 | 0.090 |
Why?
|
| Amino Acid Motifs | 3 | 2019 | 924 | 0.090 |
Why?
|
| Rats, Inbred F344 | 8 | 2000 | 822 | 0.090 |
Why?
|
| Wiskott-Aldrich Syndrome | 1 | 2011 | 131 | 0.090 |
Why?
|
| Genomics | 3 | 2018 | 5929 | 0.090 |
Why?
|
| Serum Amyloid A Protein | 1 | 2011 | 127 | 0.090 |
Why?
|
| Interleukin-1 | 3 | 2012 | 1243 | 0.090 |
Why?
|
| Dietary Proteins | 1 | 2016 | 959 | 0.090 |
Why?
|
| Asthma, Aspirin-Induced | 1 | 2014 | 204 | 0.090 |
Why?
|
| Binding Sites | 3 | 2014 | 6001 | 0.090 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2012 | 177 | 0.090 |
Why?
|
| Membrane Proteins | 4 | 2021 | 7851 | 0.090 |
Why?
|
| Genetic Association Studies | 2 | 2018 | 2741 | 0.090 |
Why?
|
| High-Throughput Screening Assays | 2 | 2021 | 938 | 0.090 |
Why?
|
| Ethmoid Sinus | 1 | 2010 | 58 | 0.090 |
Why?
|
| Clonal Anergy | 1 | 2011 | 169 | 0.090 |
Why?
|
| Genome, Human | 2 | 2014 | 4448 | 0.090 |
Why?
|
| Carrier Proteins | 2 | 1994 | 4913 | 0.090 |
Why?
|
| Skin Diseases | 1 | 2019 | 1088 | 0.090 |
Why?
|
| Heart Transplantation | 1 | 2024 | 3310 | 0.090 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2011 | 164 | 0.090 |
Why?
|
| Pyrazoles | 1 | 2020 | 2033 | 0.090 |
Why?
|
| Drug Approval | 1 | 2017 | 818 | 0.090 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2011 | 178 | 0.080 |
Why?
|
| Weight Loss | 1 | 2021 | 2710 | 0.080 |
Why?
|
| Attitude to Health | 1 | 2019 | 2020 | 0.080 |
Why?
|
| STAT1 Transcription Factor | 1 | 2011 | 339 | 0.080 |
Why?
|
| Age of Onset | 1 | 2017 | 3344 | 0.080 |
Why?
|
| Biosensing Techniques | 1 | 2016 | 642 | 0.080 |
Why?
|
| Cell Count | 2 | 2012 | 1823 | 0.080 |
Why?
|
| Behavior Therapy | 1 | 2015 | 884 | 0.080 |
Why?
|
| GPI-Linked Proteins | 1 | 2011 | 472 | 0.080 |
Why?
|
| Thrombocytopenia, Neonatal Alloimmune | 1 | 2009 | 19 | 0.080 |
Why?
|
| Data Collection | 1 | 2019 | 3318 | 0.080 |
Why?
|
| Transcription, Genetic | 4 | 2021 | 7599 | 0.080 |
Why?
|
| Vitamin D | 2 | 2021 | 3272 | 0.080 |
Why?
|
| Vancomycin | 1 | 2012 | 504 | 0.080 |
Why?
|
| Prognosis | 3 | 2018 | 29922 | 0.080 |
Why?
|
| Physical Examination | 1 | 2015 | 1266 | 0.080 |
Why?
|
| Chemokines, CC | 1 | 2010 | 285 | 0.080 |
Why?
|
| Age Factors | 3 | 2021 | 18380 | 0.080 |
Why?
|
| Epoprostenol | 1 | 2010 | 246 | 0.080 |
Why?
|
| High-Throughput Nucleotide Sequencing | 5 | 2021 | 3655 | 0.080 |
Why?
|
| Interleukin-5 | 2 | 2021 | 268 | 0.080 |
Why?
|
| Diagnosis, Differential | 2 | 2015 | 12976 | 0.080 |
Why?
|
| Receptors, CCR8 | 1 | 2009 | 28 | 0.080 |
Why?
|
| Fluorescent Dyes | 1 | 2017 | 1930 | 0.080 |
Why?
|
| Immune Sera | 2 | 2021 | 601 | 0.080 |
Why?
|
| Leukocytes, Mononuclear | 3 | 2023 | 1857 | 0.080 |
Why?
|
| Receptors, CCR4 | 1 | 2009 | 75 | 0.080 |
Why?
|
| Retrospective Studies | 8 | 2023 | 81514 | 0.080 |
Why?
|
| Natural Cytotoxicity Triggering Receptor 3 | 1 | 2008 | 14 | 0.080 |
Why?
|
| Protein Multimerization | 1 | 2014 | 959 | 0.080 |
Why?
|
| Genetic Loci | 2 | 2021 | 2631 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2023 | 10383 | 0.080 |
Why?
|
| Chromatin | 1 | 2020 | 2980 | 0.080 |
Why?
|
| Molecular Weight | 4 | 2017 | 2163 | 0.080 |
Why?
|
| C-Reactive Protein | 1 | 2020 | 3850 | 0.080 |
Why?
|
| Natural Cytotoxicity Triggering Receptor 1 | 1 | 2008 | 29 | 0.080 |
Why?
|
| Antigens, Differentiation | 5 | 1998 | 919 | 0.080 |
Why?
|
| Amiodarone | 1 | 2010 | 216 | 0.080 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2014 | 781 | 0.080 |
Why?
|
| Interleukin-1beta | 1 | 2014 | 1028 | 0.080 |
Why?
|
| Healthcare Disparities | 1 | 2024 | 3413 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 4 | 2019 | 4772 | 0.080 |
Why?
|
| Plant Extracts | 1 | 2012 | 496 | 0.070 |
Why?
|
| Drug Hypersensitivity | 1 | 2017 | 902 | 0.070 |
Why?
|
| Injections, Subcutaneous | 2 | 2020 | 682 | 0.070 |
Why?
|
| Child Development | 1 | 2020 | 2327 | 0.070 |
Why?
|
| Poverty | 1 | 2020 | 2714 | 0.070 |
Why?
|
| Aged, 80 and over | 6 | 2021 | 59489 | 0.070 |
Why?
|
| Child Abuse | 1 | 1997 | 1090 | 0.070 |
Why?
|
| Pregnancy Complications | 1 | 2022 | 2975 | 0.070 |
Why?
|
| HL-60 Cells | 1 | 2008 | 364 | 0.070 |
Why?
|
| Steroids | 2 | 2023 | 933 | 0.070 |
Why?
|
| Multivariate Analysis | 1 | 2021 | 12056 | 0.070 |
Why?
|
| Transcriptional Activation | 1 | 2014 | 1744 | 0.070 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2008 | 128 | 0.070 |
Why?
|
| Family | 2 | 2019 | 3209 | 0.070 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily B | 1 | 2007 | 85 | 0.070 |
Why?
|
| Students, Medical | 1 | 2021 | 1959 | 0.070 |
Why?
|
| NF-kappa B | 3 | 2022 | 2485 | 0.070 |
Why?
|
| Antigens, Viral | 2 | 2022 | 995 | 0.070 |
Why?
|
| Safety | 1 | 2012 | 1157 | 0.070 |
Why?
|
| Antigen Presentation | 1 | 2013 | 1250 | 0.070 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2022 | 1043 | 0.070 |
Why?
|
| Administration, Cutaneous | 2 | 2021 | 715 | 0.070 |
Why?
|
| Chromosome Mapping | 2 | 2014 | 4618 | 0.070 |
Why?
|
| Escherichia coli | 3 | 2022 | 4214 | 0.070 |
Why?
|
| Aging | 3 | 2022 | 8731 | 0.070 |
Why?
|
| Protozoan Proteins | 2 | 1998 | 843 | 0.070 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2009 | 453 | 0.070 |
Why?
|
| Kinetics | 6 | 2021 | 6274 | 0.070 |
Why?
|
| Canada | 3 | 2020 | 2119 | 0.070 |
Why?
|
| Telemedicine | 1 | 2024 | 3105 | 0.070 |
Why?
|
| Granzymes | 1 | 2008 | 278 | 0.070 |
Why?
|
| South Africa | 2 | 2023 | 1867 | 0.070 |
Why?
|
| Time Factors | 6 | 2020 | 40065 | 0.070 |
Why?
|
| Dietary Supplements | 1 | 2019 | 3425 | 0.070 |
Why?
|
| Codon, Nonsense | 1 | 2008 | 288 | 0.070 |
Why?
|
| Sequence Alignment | 3 | 2019 | 2171 | 0.070 |
Why?
|
| Models, Statistical | 1 | 2021 | 5089 | 0.070 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 612 | 0.060 |
Why?
|
| Saccharomyces cerevisiae | 3 | 1998 | 2674 | 0.060 |
Why?
|
| Homeodomain Proteins | 1 | 2015 | 2428 | 0.060 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2021 | 4058 | 0.060 |
Why?
|
| Amide Synthases | 2 | 1998 | 14 | 0.060 |
Why?
|
| Cohort Studies | 6 | 2024 | 41649 | 0.060 |
Why?
|
| Condylomata Acuminata | 1 | 2006 | 79 | 0.060 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2010 | 769 | 0.060 |
Why?
|
| Risk Assessment | 2 | 2020 | 24282 | 0.060 |
Why?
|
| DNA Copy Number Variations | 1 | 2014 | 2045 | 0.060 |
Why?
|
| Graft Survival | 1 | 1996 | 3890 | 0.060 |
Why?
|
| Genital Diseases, Male | 1 | 2006 | 84 | 0.060 |
Why?
|
| Down-Regulation | 2 | 2011 | 2927 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 4 | 2017 | 1724 | 0.060 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2013 | 1936 | 0.060 |
Why?
|
| Follow-Up Studies | 4 | 2020 | 39193 | 0.060 |
Why?
|
| Cell Separation | 1 | 2010 | 1718 | 0.060 |
Why?
|
| Genital Diseases, Female | 1 | 2006 | 193 | 0.060 |
Why?
|
| Sirolimus | 1 | 2012 | 1545 | 0.060 |
Why?
|
| Pedigree | 3 | 2017 | 4526 | 0.060 |
Why?
|
| Adiposity | 1 | 2014 | 1890 | 0.060 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 2268 | 0.060 |
Why?
|
| Education | 2 | 2019 | 533 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 4 | 2024 | 7425 | 0.060 |
Why?
|
| Intestines | 1 | 2013 | 1906 | 0.060 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2010 | 2587 | 0.060 |
Why?
|
| Viral Proteins | 2 | 2021 | 1797 | 0.060 |
Why?
|
| Spleen | 3 | 2021 | 2296 | 0.060 |
Why?
|
| Quality Improvement | 1 | 2019 | 3853 | 0.060 |
Why?
|
| Health Status | 1 | 1997 | 4080 | 0.050 |
Why?
|
| Repressor Proteins | 1 | 2014 | 2968 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 6 | 2023 | 22332 | 0.050 |
Why?
|
| Phosphate-Binding Proteins | 1 | 2024 | 93 | 0.050 |
Why?
|
| Biopsy | 2 | 2014 | 6763 | 0.050 |
Why?
|
| RNA, Viral | 2 | 2022 | 2864 | 0.050 |
Why?
|
| Neointima | 1 | 2024 | 133 | 0.050 |
Why?
|
| Reproducibility of Results | 4 | 2023 | 20124 | 0.050 |
Why?
|
| Irritants | 1 | 2023 | 42 | 0.050 |
Why?
|
| Psoriasis | 1 | 2011 | 919 | 0.050 |
Why?
|
| Macadamia | 1 | 2022 | 1 | 0.050 |
Why?
|
| Pneumonia | 2 | 2017 | 2157 | 0.050 |
Why?
|
| Pulsatile Flow | 1 | 2024 | 318 | 0.050 |
Why?
|
| Cytophotometry | 1 | 2022 | 8 | 0.050 |
Why?
|
| Receptors, CCR7 | 1 | 2023 | 104 | 0.050 |
Why?
|
| Turbinates | 1 | 2023 | 66 | 0.050 |
Why?
|
| Breast Feeding | 2 | 2021 | 1364 | 0.050 |
Why?
|
| Aspirin | 1 | 2014 | 3134 | 0.050 |
Why?
|
| Trypanosoma congolense | 2 | 1992 | 3 | 0.050 |
Why?
|
| Mass Screening | 1 | 2018 | 5446 | 0.050 |
Why?
|
| Selenomethionine | 1 | 2022 | 18 | 0.050 |
Why?
|
| Immunodominant Epitopes | 1 | 2023 | 244 | 0.050 |
Why?
|
| Neoplasm Proteins | 1 | 2014 | 3596 | 0.050 |
Why?
|
| Apoptosis | 3 | 2018 | 9514 | 0.050 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2011 | 2423 | 0.050 |
Why?
|
| Obesity | 2 | 2021 | 13076 | 0.050 |
Why?
|
| Immunoglobulin Isotypes | 1 | 2022 | 157 | 0.050 |
Why?
|
| Tetanus Toxoid | 1 | 2022 | 188 | 0.050 |
Why?
|
| Receptors, KIR | 1 | 2022 | 114 | 0.050 |
Why?
|
| Cooking | 1 | 2024 | 327 | 0.050 |
Why?
|
| Mongolia | 1 | 2021 | 93 | 0.050 |
Why?
|
| Cullin Proteins | 1 | 2022 | 178 | 0.050 |
Why?
|
| Administration, Topical | 1 | 2023 | 704 | 0.050 |
Why?
|
| Reference Values | 2 | 2024 | 4908 | 0.050 |
Why?
|
| Hypertrophy | 1 | 2023 | 559 | 0.050 |
Why?
|
| Immunoglobulin D | 1 | 2021 | 55 | 0.050 |
Why?
|
| Boston | 2 | 2024 | 9338 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2011 | 2880 | 0.050 |
Why?
|
| Leishmania | 2 | 1992 | 75 | 0.050 |
Why?
|
| Sesamum | 1 | 2020 | 18 | 0.050 |
Why?
|
| Pesticides | 1 | 2024 | 296 | 0.050 |
Why?
|
| DNA Mutational Analysis | 3 | 2017 | 4108 | 0.050 |
Why?
|
| Lung | 2 | 2023 | 10033 | 0.050 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 1 | 2021 | 102 | 0.040 |
Why?
|
| Combined Modality Therapy | 3 | 2017 | 8529 | 0.040 |
Why?
|
| Immunogenetics | 1 | 2020 | 62 | 0.040 |
Why?
|
| Diet Therapy | 1 | 2021 | 149 | 0.040 |
Why?
|
| DNA-Binding Proteins | 2 | 2015 | 9601 | 0.040 |
Why?
|
| Homeostasis | 2 | 2022 | 3336 | 0.040 |
Why?
|
| Epidermis | 1 | 2023 | 538 | 0.040 |
Why?
|
| Critical Pathways | 1 | 2024 | 474 | 0.040 |
Why?
|
| Prospective Studies | 5 | 2024 | 54802 | 0.040 |
Why?
|
| Antihypertensive Agents | 1 | 2010 | 2033 | 0.040 |
Why?
|
| Austria | 1 | 2020 | 206 | 0.040 |
Why?
|
| Infant Food | 1 | 2021 | 139 | 0.040 |
Why?
|
| Spirometry | 2 | 2014 | 929 | 0.040 |
Why?
|
| Genes, Immunoglobulin | 1 | 2021 | 285 | 0.040 |
Why?
|
| Peptide Library | 1 | 2021 | 351 | 0.040 |
Why?
|
| Health Services Needs and Demand | 2 | 2019 | 1406 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2009 | 2453 | 0.040 |
Why?
|
| Toll-Like Receptors | 2 | 2015 | 583 | 0.040 |
Why?
|
| Antibodies, Antinuclear | 1 | 2021 | 340 | 0.040 |
Why?
|
| Immunity, Mucosal | 1 | 2023 | 498 | 0.040 |
Why?
|
| Epitopes, B-Lymphocyte | 1 | 2020 | 84 | 0.040 |
Why?
|
| Sequence Analysis | 1 | 2020 | 239 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2022 | 353 | 0.040 |
Why?
|
| Dogs | 1 | 2024 | 3822 | 0.040 |
Why?
|
| Ferrosoferric Oxide | 1 | 2021 | 349 | 0.040 |
Why?
|
| Staining and Labeling | 1 | 2024 | 1072 | 0.040 |
Why?
|
| Infant Formula | 1 | 2021 | 192 | 0.040 |
Why?
|
| Cough | 1 | 2023 | 597 | 0.040 |
Why?
|
| Blood Donors | 1 | 2021 | 342 | 0.040 |
Why?
|
| Consensus Development Conferences, NIH as Topic | 1 | 2019 | 29 | 0.040 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2021 | 289 | 0.040 |
Why?
|
| Zoonoses | 1 | 2020 | 181 | 0.040 |
Why?
|
| Interferon-alpha | 1 | 2023 | 910 | 0.040 |
Why?
|
| Housing | 1 | 2024 | 683 | 0.040 |
Why?
|
| Immunization, Passive | 1 | 2021 | 616 | 0.040 |
Why?
|
| National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2019 | 62 | 0.040 |
Why?
|
| Rats, Inbred Strains | 2 | 1998 | 2077 | 0.040 |
Why?
|
| RNA, Bacterial | 1 | 2021 | 392 | 0.040 |
Why?
|
| Receptors, Prostaglandin | 1 | 2018 | 54 | 0.040 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2021 | 755 | 0.040 |
Why?
|
| Troponin | 1 | 2022 | 533 | 0.040 |
Why?
|
| Immunization, Secondary | 1 | 2021 | 373 | 0.040 |
Why?
|
| Chromatography, Gel | 2 | 2017 | 629 | 0.040 |
Why?
|
| Paris | 1 | 2018 | 40 | 0.040 |
Why?
|
| Genome, Viral | 1 | 2022 | 670 | 0.040 |
Why?
|
| Ebolavirus | 1 | 2021 | 250 | 0.040 |
Why?
|
| Liver | 1 | 2014 | 7562 | 0.040 |
Why?
|
| Proteins | 1 | 2013 | 5995 | 0.040 |
Why?
|
| Losartan | 1 | 2000 | 263 | 0.040 |
Why?
|
| Connective Tissue Diseases | 1 | 2021 | 284 | 0.040 |
Why?
|
| DNA, Bacterial | 1 | 2023 | 1477 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 2 | 2017 | 6220 | 0.040 |
Why?
|
| Interleukin-2 | 2 | 2022 | 1896 | 0.040 |
Why?
|
| Genetic Determinism | 1 | 2017 | 11 | 0.040 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2021 | 545 | 0.040 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2012 | 2429 | 0.040 |
Why?
|
| Immunity, Humoral | 1 | 2022 | 605 | 0.040 |
Why?
|
| Lymphopenia | 1 | 2020 | 297 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2022 | 1718 | 0.040 |
Why?
|
| Hematologic Neoplasms | 1 | 2009 | 1927 | 0.040 |
Why?
|
| IMP Dehydrogenase | 1 | 2017 | 34 | 0.040 |
Why?
|
| cis-trans-Isomerases | 1 | 2017 | 45 | 0.040 |
Why?
|
| Cell Proliferation | 4 | 2017 | 10429 | 0.040 |
Why?
|
| DNA, Protozoan | 3 | 1994 | 226 | 0.040 |
Why?
|
| Host-Parasite Interactions | 1 | 2020 | 302 | 0.040 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2018 | 412 | 0.040 |
Why?
|
| Glycosylation | 1 | 2020 | 1100 | 0.040 |
Why?
|
| Mucins | 2 | 1997 | 567 | 0.040 |
Why?
|
| Interferons | 1 | 2021 | 714 | 0.040 |
Why?
|
| Immunohistochemistry | 4 | 2014 | 11022 | 0.040 |
Why?
|
| Proteinuria | 5 | 1997 | 607 | 0.040 |
Why?
|
| Algorithms | 1 | 2018 | 14071 | 0.040 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2017 | 355 | 0.040 |
Why?
|
| T-Cell Antigen Receptor Specificity | 1 | 2017 | 89 | 0.030 |
Why?
|
| Interleukin-6 | 4 | 2020 | 3222 | 0.030 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2020 | 418 | 0.030 |
Why?
|
| Risk | 2 | 2021 | 9591 | 0.030 |
Why?
|
| Hemophilia A | 1 | 2000 | 357 | 0.030 |
Why?
|
| Pregnant Women | 1 | 2022 | 575 | 0.030 |
Why?
|
| Chemical Precipitation | 1 | 2017 | 173 | 0.030 |
Why?
|
| Neuroimmunomodulation | 1 | 2019 | 186 | 0.030 |
Why?
|
| Microfluidics | 1 | 2022 | 651 | 0.030 |
Why?
|
| Caseins | 1 | 2017 | 105 | 0.030 |
Why?
|
| Creatinine | 1 | 2022 | 1915 | 0.030 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2017 | 162 | 0.030 |
Why?
|
| Circular Dichroism | 1 | 2017 | 331 | 0.030 |
Why?
|
| Patient Dropouts | 1 | 2019 | 410 | 0.030 |
Why?
|
| Mice, Inbred C3H | 1 | 2017 | 914 | 0.030 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2020 | 637 | 0.030 |
Why?
|
| Drug Design | 2 | 1992 | 1042 | 0.030 |
Why?
|
| Organ Preservation Solutions | 1 | 1997 | 105 | 0.030 |
Why?
|
| Glutens | 1 | 2018 | 240 | 0.030 |
Why?
|
| Ciprofloxacin | 1 | 1998 | 314 | 0.030 |
Why?
|
| Immunoglobulin M | 1 | 2021 | 1528 | 0.030 |
Why?
|
| Blood Proteins | 1 | 2021 | 1188 | 0.030 |
Why?
|
| Endoscopy, Digestive System | 1 | 2018 | 358 | 0.030 |
Why?
|
| DNA, Complementary | 1 | 2019 | 1984 | 0.030 |
Why?
|
| Foster Home Care | 1 | 1997 | 140 | 0.030 |
Why?
|
| Nutritional Status | 1 | 2024 | 1620 | 0.030 |
Why?
|
| Edetic Acid | 1 | 2016 | 274 | 0.030 |
Why?
|
| Nephrons | 1 | 1997 | 165 | 0.030 |
Why?
|
| Group Processes | 1 | 2017 | 224 | 0.030 |
Why?
|
| Polysaccharides | 1 | 2022 | 1016 | 0.030 |
Why?
|
| Chromatography, Ion Exchange | 2 | 1992 | 289 | 0.030 |
Why?
|
| Skin Neoplasms | 1 | 2015 | 5849 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 14652 | 0.030 |
Why?
|
| Sulfhydryl Compounds | 1 | 2017 | 296 | 0.030 |
Why?
|
| Histamine | 1 | 2017 | 497 | 0.030 |
Why?
|
| Autoimmunity | 2 | 2015 | 1354 | 0.030 |
Why?
|
| Interleukin-3 | 1 | 2016 | 423 | 0.030 |
Why?
|
| Mexico | 1 | 2017 | 777 | 0.030 |
Why?
|
| Cholesterol, HDL | 1 | 2021 | 1811 | 0.030 |
Why?
|
| Limit of Detection | 1 | 2016 | 272 | 0.030 |
Why?
|
| Receptors, Cytokine | 1 | 1996 | 258 | 0.030 |
Why?
|
| Prisons | 1 | 1997 | 178 | 0.030 |
Why?
|
| Brain Death | 1 | 1998 | 360 | 0.030 |
Why?
|
| Myosin Type II | 1 | 2014 | 71 | 0.030 |
Why?
|
| Macrophage Activation | 1 | 1997 | 552 | 0.030 |
Why?
|
| Minority Groups | 1 | 2022 | 1207 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2000 | 1441 | 0.030 |
Why?
|
| Furans | 1 | 1995 | 198 | 0.030 |
Why?
|
| Leukocytes | 1 | 2022 | 2027 | 0.030 |
Why?
|
| Forced Expiratory Flow Rates | 1 | 2014 | 77 | 0.030 |
Why?
|
| Intention to Treat Analysis | 1 | 2015 | 416 | 0.030 |
Why?
|
| HSC70 Heat-Shock Proteins | 1 | 1994 | 48 | 0.030 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2017 | 394 | 0.030 |
Why?
|
| Nicotine | 1 | 2019 | 682 | 0.030 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2017 | 568 | 0.030 |
Why?
|
| Electric Impedance | 1 | 2018 | 794 | 0.030 |
Why?
|
| RNA Splicing | 1 | 2018 | 903 | 0.030 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2020 | 1499 | 0.030 |
Why?
|
| Triage | 1 | 2021 | 996 | 0.030 |
Why?
|
| Triglycerides | 1 | 2021 | 2441 | 0.030 |
Why?
|
| Mutation, Missense | 2 | 2014 | 2589 | 0.030 |
Why?
|
| Cross-Linking Reagents | 1 | 2017 | 687 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2020 | 1192 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 3807 | 0.030 |
Why?
|
| Antibody Specificity | 1 | 2015 | 1061 | 0.030 |
Why?
|
| Outpatients | 1 | 2021 | 1595 | 0.030 |
Why?
|
| Administration, Inhalation | 1 | 2016 | 1154 | 0.030 |
Why?
|
| Organ Preservation | 1 | 1997 | 399 | 0.030 |
Why?
|
| Disease Outbreaks | 1 | 2023 | 1759 | 0.030 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2017 | 833 | 0.030 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2011 | 5753 | 0.030 |
Why?
|
| Sex Factors | 2 | 2019 | 10603 | 0.030 |
Why?
|
| Magnetics | 1 | 2016 | 585 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2015 | 1770 | 0.030 |
Why?
|
| Temperature | 2 | 2016 | 2226 | 0.030 |
Why?
|
| Cyclosporins | 1 | 1993 | 216 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2021 | 2354 | 0.030 |
Why?
|
| Peptidylprolyl Isomerase | 1 | 1993 | 98 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 1994 | 1140 | 0.030 |
Why?
|
| Point-of-Care Systems | 1 | 2021 | 1217 | 0.030 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2015 | 384 | 0.030 |
Why?
|
| Immunization | 1 | 2017 | 1219 | 0.020 |
Why?
|
| Crithidia | 1 | 1992 | 2 | 0.020 |
Why?
|
| Th1-Th2 Balance | 1 | 2012 | 38 | 0.020 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2012 | 140 | 0.020 |
Why?
|
| Genotype | 3 | 2011 | 13024 | 0.020 |
Why?
|
| Glutathione Reductase | 1 | 1992 | 25 | 0.020 |
Why?
|
| Anemia, Aplastic | 1 | 2014 | 232 | 0.020 |
Why?
|
| Ischemia | 2 | 1997 | 1909 | 0.020 |
Why?
|
| Cholesterol, LDL | 1 | 2021 | 2393 | 0.020 |
Why?
|
| Trypanosomiasis, African | 1 | 1992 | 30 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2016 | 1749 | 0.020 |
Why?
|
| India | 1 | 2018 | 2334 | 0.020 |
Why?
|
| Hematopoiesis | 1 | 2021 | 2058 | 0.020 |
Why?
|
| Blood Cell Count | 1 | 2012 | 405 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2013 | 545 | 0.020 |
Why?
|
| Leishmania tropica | 1 | 1991 | 7 | 0.020 |
Why?
|
| Incidence | 2 | 2024 | 21480 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 1992 | 1679 | 0.020 |
Why?
|
| Cell Line | 3 | 2016 | 15543 | 0.020 |
Why?
|
| Child Health Services | 1 | 1997 | 645 | 0.020 |
Why?
|
| Phlebotomus | 1 | 1991 | 12 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2019 | 2140 | 0.020 |
Why?
|
| Protein Binding | 2 | 1994 | 9296 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2020 | 4260 | 0.020 |
Why?
|
| Respiratory Sounds | 1 | 2015 | 705 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2012 | 2476 | 0.020 |
Why?
|
| Drug Resistance | 2 | 2014 | 1591 | 0.020 |
Why?
|
| Mice, Knockout | 2 | 2020 | 14448 | 0.020 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2012 | 168 | 0.020 |
Why?
|
| Protein Transport | 1 | 2017 | 1939 | 0.020 |
Why?
|
| Liver Function Tests | 1 | 2012 | 525 | 0.020 |
Why?
|
| Ligases | 1 | 1992 | 330 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1992 | 705 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 2034 | 0.020 |
Why?
|
| Ear, Inner | 1 | 2014 | 425 | 0.020 |
Why?
|
| Body Mass Index | 2 | 2021 | 13039 | 0.020 |
Why?
|
| beta-Glucans | 1 | 2011 | 129 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2019 | 1461 | 0.020 |
Why?
|
| Alleles | 1 | 2022 | 6897 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 1998 | 986 | 0.020 |
Why?
|
| Caregivers | 1 | 2023 | 2307 | 0.020 |
Why?
|
| Rural Population | 1 | 2021 | 2317 | 0.020 |
Why?
|
| Consensus | 1 | 2020 | 3202 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2018 | 1892 | 0.020 |
Why?
|
| Fruit | 1 | 2015 | 1166 | 0.020 |
Why?
|
| Vegetables | 1 | 2015 | 1199 | 0.020 |
Why?
|
| Chagas Disease | 1 | 1992 | 163 | 0.020 |
Why?
|
| Critical Illness | 1 | 2023 | 2744 | 0.020 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2022 | 2187 | 0.020 |
Why?
|
| Alanine Transaminase | 1 | 2012 | 607 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 2017 | 1792 | 0.020 |
Why?
|
| Recombinant Proteins | 3 | 1998 | 6493 | 0.020 |
Why?
|
| Lymphocyte Count | 1 | 2012 | 790 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2021 | 3312 | 0.020 |
Why?
|
| Patient Care Team | 1 | 2021 | 2517 | 0.020 |
Why?
|
| Genes, Viral | 1 | 1991 | 654 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2021 | 3454 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2013 | 723 | 0.020 |
Why?
|
| Virus Diseases | 1 | 2015 | 718 | 0.020 |
Why?
|
| Disease Management | 1 | 2020 | 2535 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2020 | 2709 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2017 | 2412 | 0.020 |
Why?
|
| Proton Pump Inhibitors | 1 | 2014 | 553 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2021 | 16047 | 0.020 |
Why?
|
| Glucose | 1 | 2021 | 4335 | 0.020 |
Why?
|
| Oxidation-Reduction | 2 | 1992 | 2218 | 0.020 |
Why?
|
| Heparin | 1 | 2016 | 1630 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2021 | 10729 | 0.020 |
Why?
|
| Lymphoma, B-Cell | 1 | 2015 | 943 | 0.020 |
Why?
|
| Histocompatibility Antigens Class II | 3 | 1997 | 1441 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2011 | 898 | 0.020 |
Why?
|
| Longitudinal Studies | 2 | 2017 | 14751 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 1994 | 3051 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2016 | 3946 | 0.020 |
Why?
|
| Thymus Gland | 1 | 2013 | 1261 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1992 | 2745 | 0.020 |
Why?
|
| Asymptomatic Diseases | 1 | 2011 | 586 | 0.020 |
Why?
|
| Protein Engineering | 1 | 1992 | 550 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2017 | 2867 | 0.020 |
Why?
|
| Heterozygote | 1 | 2014 | 2794 | 0.020 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2011 | 891 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 1992 | 1752 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2012 | 1638 | 0.020 |
Why?
|
| Equipment Design | 1 | 2016 | 3481 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2021 | 3985 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2015 | 4850 | 0.020 |
Why?
|
| Health Behavior | 1 | 2019 | 2650 | 0.020 |
Why?
|
| Endothelins | 2 | 1997 | 127 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2014 | 2721 | 0.020 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2009 | 283 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2011 | 1336 | 0.020 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2019 | 1883 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2017 | 1808 | 0.020 |
Why?
|
| Health Personnel | 1 | 2021 | 3390 | 0.020 |
Why?
|
| Hypertension | 2 | 2020 | 8626 | 0.020 |
Why?
|
| Simplexvirus | 1 | 1991 | 807 | 0.020 |
Why?
|
| Gene Library | 1 | 2009 | 1067 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2020 | 5343 | 0.020 |
Why?
|
| Recombination, Genetic | 1 | 1991 | 1525 | 0.020 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2022 | 3733 | 0.020 |
Why?
|
| Stem Cell Transplantation | 1 | 2014 | 1602 | 0.020 |
Why?
|
| Kidney Glomerulus | 2 | 2000 | 568 | 0.020 |
Why?
|
| Acute Kidney Injury | 1 | 1998 | 1946 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2010 | 1417 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2011 | 1966 | 0.020 |
Why?
|
| Prednisone | 1 | 2010 | 1565 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 3 | 1997 | 1995 | 0.020 |
Why?
|
| DNA Primers | 1 | 2009 | 2825 | 0.020 |
Why?
|
| Antibodies | 1 | 2013 | 2417 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2017 | 9649 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 3797 | 0.010 |
Why?
|
| Drosophila | 1 | 1992 | 1501 | 0.010 |
Why?
|
| Neoplasm, Residual | 1 | 2009 | 1009 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1995 | 8102 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 9550 | 0.010 |
Why?
|
| Linear Models | 1 | 2014 | 5876 | 0.010 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1991 | 1365 | 0.010 |
Why?
|
| ROC Curve | 1 | 2012 | 3620 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2023 | 7875 | 0.010 |
Why?
|
| Anxiety | 1 | 2019 | 4671 | 0.010 |
Why?
|
| Thrombocytopenia | 1 | 2011 | 1171 | 0.010 |
Why?
|
| Child Abuse, Sexual | 1 | 2006 | 397 | 0.010 |
Why?
|
| Research Design | 1 | 2019 | 6209 | 0.010 |
Why?
|
| Registries | 1 | 2019 | 8297 | 0.010 |
Why?
|
| Nephrectomy | 2 | 1997 | 927 | 0.010 |
Why?
|
| Liver Transplantation | 1 | 2014 | 2412 | 0.010 |
Why?
|
| Blotting, Southern | 2 | 1994 | 772 | 0.010 |
Why?
|
| Logistic Models | 1 | 2015 | 13266 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2011 | 4159 | 0.010 |
Why?
|
| Anticoagulants | 1 | 2016 | 4862 | 0.010 |
Why?
|
| Ligands | 2 | 1997 | 3273 | 0.010 |
Why?
|
| Receptor, Angiotensin, Type 2 | 1 | 2000 | 61 | 0.010 |
Why?
|
| Papillomaviridae | 1 | 2006 | 1141 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 1992 | 5125 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2010 | 4247 | 0.010 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2000 | 153 | 0.010 |
Why?
|
| Trazodone | 1 | 1998 | 67 | 0.010 |
Why?
|
| Hemodynamics | 2 | 2000 | 4184 | 0.010 |
Why?
|
| Complement C1 | 1 | 1997 | 28 | 0.010 |
Why?
|
| Raffinose | 1 | 1997 | 57 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2010 | 5993 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2012 | 6610 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2012 | 8067 | 0.010 |
Why?
|
| Endothelin-1 | 1 | 1997 | 295 | 0.010 |
Why?
|
| Allopurinol | 1 | 1997 | 203 | 0.010 |
Why?
|
| Complement C3 | 1 | 1997 | 424 | 0.010 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 1998 | 490 | 0.010 |
Why?
|
| E-Selectin | 1 | 1997 | 576 | 0.010 |
Why?
|
| Isoantigens | 1 | 1996 | 562 | 0.010 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 1997 | 333 | 0.010 |
Why?
|
| Molecular Structure | 1 | 1998 | 1885 | 0.010 |
Why?
|
| Cold Temperature | 1 | 1997 | 794 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2009 | 8611 | 0.010 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2000 | 1061 | 0.010 |
Why?
|
| Referral and Consultation | 1 | 2006 | 3615 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1998 | 4165 | 0.010 |
Why?
|
| Interleukins | 1 | 1997 | 791 | 0.010 |
Why?
|
| Cryopreservation | 1 | 1997 | 728 | 0.010 |
Why?
|
| Deuterium | 1 | 1992 | 104 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2006 | 7838 | 0.010 |
Why?
|
| Organ Size | 1 | 1997 | 2260 | 0.010 |
Why?
|
| Adenosine | 1 | 1997 | 806 | 0.010 |
Why?
|
| Tritium | 1 | 1992 | 702 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 1994 | 562 | 0.010 |
Why?
|
| NADP | 1 | 1992 | 229 | 0.010 |
Why?
|
| Solvents | 1 | 1992 | 299 | 0.010 |
Why?
|
| Bucladesine | 1 | 1991 | 117 | 0.010 |
Why?
|
| TATA Box | 1 | 1991 | 127 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1991 | 848 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 1997 | 2216 | 0.010 |
Why?
|
| Vero Cells | 1 | 1991 | 481 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1991 | 822 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1991 | 1306 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1992 | 1526 | 0.000 |
Why?
|
| Oligopeptides | 1 | 1994 | 1192 | 0.000 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 1991 | 499 | 0.000 |
Why?
|
| Glomerular Filtration Rate | 1 | 1997 | 2233 | 0.000 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2012 | 12240 | 0.000 |
Why?
|
| Nerve Growth Factors | 1 | 1991 | 565 | 0.000 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1992 | 2477 | 0.000 |
Why?
|
| Acute Disease | 1 | 1998 | 7232 | 0.000 |
Why?
|
| Species Specificity | 1 | 1991 | 2406 | 0.000 |
Why?
|
| Body Weight | 1 | 1997 | 4622 | 0.000 |
Why?
|
| Kidney Diseases | 1 | 1997 | 2098 | 0.000 |
Why?
|
| Gene Amplification | 1 | 1991 | 1091 | 0.000 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1994 | 3737 | 0.000 |
Why?
|
| Bacterial Proteins | 1 | 1998 | 3837 | 0.000 |
Why?
|
| Genetic Markers | 1 | 1991 | 2601 | 0.000 |
Why?
|
| Insulin | 1 | 1997 | 6599 | 0.000 |
Why?
|